Genomic Biomarkers MarketGenomic Biomarkers Market By Type (Predictive Biomarkers and Prognostic Biomarkers), By Disease Indication (Oncology, Neurological Diseases, Renal Disorders, Cardiovascular Diseases, and Other Disease Indications) By End-User (Hospitals, Diagnostic, Research Laboratories, and, Other End-Users), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: July 2024
Report ID: 124487
Number of Pages: 306
Format:

Fact Checked

Cite this Research

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    
    2.2.1. Drivers
    
    2.2.2. Restraints
    
    2.2.3. Opportunities
    
    2.2.4. Key Inhalable Drugs Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    
    2.9.1. List of Raw Materials Suppliers
    
    2.9.2. List of Inhalable Drugs Manufacturers
    
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Inhalable Drugs Market Analysis and Forecast, By Segment, 2018-2033
  - 3.1. Key Findings
  - 3.2. Global Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2018-2033
  - 3.3. Global Inhalable Drugs Market Attractiveness Analysis, By Type
    
    3.3.1. Predictive Biomarkers
    
    3.3.1.1. Insights
    
    3.3.1.2. Key Takeaways
    
    3.3.2. Prognostic Biomarkers
    
    3.3.2.1. Insights
    
    3.3.2.2. Key Takeaways
  - 3.4. Global Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Indication, 2018-2033
  - 3.5. Global Inhalable Drugs Market Attractiveness Analysis, By Disease Indication
    
    3.5.1. Oncology
    
    3.5.1.1. Insights
    
    3.5.1.2. Key Takeaways
    
    3.5.2. Neurological Diseases
    
    3.5.2.1. Insights
    
    3.5.2.2. Key Takeaways
    
    3.5.3. Renal Disorders
    
    3.5.3.1. Insights
    
    3.5.3.2. Key Takeaways
    
    3.5.4. Cardiovascular Diseases
    
    3.5.4.1. Insights
    
    3.5.4.2. Key Takeaways
    
    3.5.5. Other Disease Indications
    
    3.5.5.1. Insights
    
    3.5.5.2. Key Takeaways
    
    3.6. Global Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2018-2033
    
    3.7. Global Inhalable Drugs Market Attractiveness Analysis, By End-User
    
    3.7.1. Hospitals
    
    3.7.1.1. Insights
    
    3.7.1.2. Key Takeaways
    
    3.7.2. Diagnostic
    
    3.7.2.1. Insights
    
    3.7.2.2. Key Takeaways
    
    3.7.3. Research Laboratories
    
    3.7.3.1. Insights
    
    3.7.3.2. Key Takeaways
    
    3.7.4. Other End-Users
    
    3.7.4.1. Insights
    
    3.7.4.2. Key Takeaways
- 4. Global Inhalable Drugs Market Analysis and Forecast, By Region, 2018-2033
  - 4.1. Key Findings
  - 4.2. Global Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2018-2033
    
    4.2.1. North America
    
    4.2.1.1. Regional Insights
    
    4.2.2. Europe
    
    4.2.2.1. Regional Insights
    
    4.2.3. Asia Pacific
    
    4.2.3.1. Regional Insights
    
    4.2.4. Latin America
    
    4.2.4.1. Regional Insights
    
    4.2.5. Middle East & Africa
    
    4.2.5.1. Regional Insights
  - 4.3. Global Inhalable Drugs Market Attractiveness Analysis, By Region
- 5. North America Inhalable Drugs Market Analysis and Forecast, 2018-2033
  - 5.1. Key Findings
  - 5.2. North America Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2018-2033
  - 5.3. North America Inhalable Drugs Market Attractiveness Analysis, By Type
  - 5.4. North America Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Indication, 2018-2033
  - 5.5. North America Inhalable Drugs Market Attractiveness Analysis, By Disease Indication
  - 5.6. North America Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2018-2033
  - 5.7. North America Inhalable Drugs Market Attractiveness Analysis, By End-User
  - 5.8. North America Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2018-2033
  - 5.9. North America Inhalable Drugs Market Attractiveness Analysis, By Country
    
    5.9.1. The US
    
    5.9.2. Canada
- 6. Europe Inhalable Drugs Market Analysis and Forecast, 2018-2033
  - 6.1. Key Findings
  - 6.2. Europe Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2018-2033
  - 6.3. Europe Inhalable Drugs Market Attractiveness Analysis, By Type
  - 6.4. Europe Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Indication, 2018-2033
  - 6.5. Europe Inhalable Drugs Market Attractiveness Analysis, By Disease Indication
  - 6.6. Europe Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2018-2033
  - 6.7. Europe Inhalable Drugs Market Attractiveness Analysis, By End-User
  - 6.8. Europe Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2018-2033
  - 6.9. Europe Inhalable Drugs Market Attractiveness Analysis, By Country
    
    6.9.1. Germany
    
    6.9.2. The UK
    
    6.9.3. France
    
    6.9.4. Spain
    
    6.9.5. Italy
    
    6.9.6. Russia
    
    6.9.7. Netherlands
    
    6.9.8. Rest of Europe
- 7. Asia Pacific Inhalable Drugs Market Analysis and Forecast, 2018-2033
  - 7.1. Key Findings
  - 7.2. Asia Pacific Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2018-2033
  - 7.3. Asia Pacific Inhalable Drugs Market Attractiveness Analysis, By Type
  - 7.4. Asia Pacific Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Indication, 2018-2033
  - 7.5. Asia Pacific Inhalable Drugs Market Attractiveness Analysis, By Disease Indication
  - 7.6. Asia Pacific Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2018-2033
  - 7.7. Asia Pacific Inhalable Drugs Market Attractiveness Analysis, By End-User
  - 7.8. Asia Pacific Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2018-2033
  - 7.9. Asia Pacific Inhalable Drugs Market Attractiveness Analysis, By Country
    
    7.9.1. China
    
    7.9.2. Japan
    
    7.9.3. South Korea
    
    7.9.4. India
    
    7.9.5. New Zealand
    
    7.9.6. Singapore
    
    7.9.7. Thailand
    
    7.9.8. Vietnam
    
    7.9.9. Rest of Asia Pacific
- 8. Latin America Inhalable Drugs Market Analysis and Forecast, 2018-2033
  - 8.1. Key Findings
  - 8.2. Latin America Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2018-2033
  - 8.3. Latin America Inhalable Drugs Market Attractiveness Analysis, By Type
  - 8.4. Latin America Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Indication, 2018-2033
  - 8.5. Latin America Inhalable Drugs Market Attractiveness Analysis, By Disease Indication
  - 8.6. Latin America Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2018-2033
  - 8.7. Latin America Inhalable Drugs Market Attractiveness Analysis, By End-User
  - 8.8. Latin America Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2018-2033
  - 8.9. Latin America Inhalable Drugs Market Attractiveness Analysis, By Country
    
    8.9.1. Brazil
    
    8.9.2. Mexico
    
    8.9.3. Rest of Latin America
- 9. Middle East & Africa Inhalable Drugs Market Analysis and Forecast, 2018-2033
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2018-2033
  - 9.3. Middle East & Africa Inhalable Drugs Market Attractiveness Analysis, By Type
  - 9.4. Middle East & Africa Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease Indication, 2018-2033
  - 9.5. Middle East & Africa Inhalable Drugs Market Attractiveness Analysis, By Disease Indication
  - 9.6. Middle East & Africa Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2018-2033
  - 9.7. Middle East & Africa Inhalable Drugs Market Attractiveness Analysis, By End-User
  - 9.8. Middle East & Africa Inhalable Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2018-2033
  - 9.9. Middle East & Africa Inhalable Drugs Market Attractiveness Analysis, By Country
    
    9.9.1. South Africa
    
    9.9.2. Saudi Arabia
    
    9.9.3. UAE
    
    9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    
    10.7.1. Bio-Rad Laboratories
    
    10.7.1.1. Company Details
    
    10.7.1.2. Business Overview
    
    10.7.1.3. Type Portfolio
    
    10.7.1.4. Financial Insights
    
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Type Development)
    
    10.7.1.6. SWOT Analysis
    
    10.7.1.7. Geographic Footprint
    
    10.7.2. Almac Group
    
    10.7.2.1. Company Details
    
    10.7.2.2. Business Overview
    
    10.7.2.3. Type Portfolio
    
    10.7.2.4. Financial Insights
    
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Type Development)
    
    10.7.2.6. SWOT Analysis
    
    10.7.2.7. Geographic Footprint
    
    10.7.3. Eurofins Scientific
    
    10.7.3.1. Company Details
    
    10.7.3.2. Business Overview
    
    10.7.3.3. Type Portfolio
    
    10.7.3.4. Financial Insights
    
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Type Development)
    
    10.7.3.6. SWOT Analysis
    
    10.7.3.7. Geographic Footprint
    
    10.7.4. Cancer Genetics Inc
    
    10.7.4.1. Company Details
    
    10.7.4.2. Business Overview
    
    10.7.4.3. Type Portfolio
    
    10.7.4.4. Financial Insights
    
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Type Development)
    
    10.7.4.6. SWOT Analysis
    
    10.7.4.7. Geographic Footprint
    
    10.7.5. Thermo Fisher Scientific Inc
    
    10.7.5.1. Company Details
    
    10.7.5.2. Business Overview
    
    10.7.5.3. Type Portfolio
    
    10.7.5.4. Financial Insights
    
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Type Development)
    
    10.7.5.6. SWOT Analysis
    
    10.7.5.7. Geographic Footprint
    
    10.7.6. Epigenomics AG
    
    10.7.6.1. Company Details
    
    10.7.6.2. Business Overview
    
    10.7.6.3. Type Portfolio
    
    10.7.6.4. Financial Insights
    
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Type Development)
    
    10.7.6.6. SWOT Analysis
    
    10.7.6.7. Geographic Footprint
    
    10.7.7. US Biomarkers Inc.
    
    10.7.7.1. Company Details
    
    10.7.7.2. Business Overview
    
    10.7.7.3. Type Portfolio
    
    10.7.7.4. Financial Insights
    
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Type Development)
    
    10.7.7.6. SWOT Analysis
    
    10.7.7.7. Geographic Footprint
    
    10.7.8. Myriad Genetics
    
    10.7.8.1. Company Details
    
    10.7.8.2. Business Overview
    
    10.7.8.3. Type Portfolio
    
    10.7.8.4. Financial Insights
    
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Type Development)
    
    10.7.8.6. SWOT Analysis
    
    10.7.8.7. Geographic Footprint
    
    10.7.9. Aepodia SA
    
    10.7.9.1. Company Details
    
    10.7.9.2. Business Overview
    
    10.7.9.3. Type Portfolio
    
    10.7.9.4. Financial Insights
    
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Type Development)
    
    10.7.9.6. SWOT Analysis
    
    10.7.9.7. Geographic Footprint
    
    10.7.10. Roche Diagnostics
    
    10.7.10.1. Company Details
    
    10.7.10.2. Business Overview
    
    10.7.10.3. Type Portfolio
    
    10.7.10.4. Financial Insights
    
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Type Development)
    
    10.7.10.6. SWOT Analysis
    
    10.7.10.7. Geographic Footprint
    
    10.7.11. Other Key Players
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
- List of Tables
  - Table 1. Global Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 2. Global Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 3. Global Inhalable Drugs Market Value (US$ Mn), By Region, 2018-2033
  - Table 4. North America Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 5. North America Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 6. North America Inhalable Drugs Market Value (US$ Mn), By Country, 2018-2033
  - Table 7. The US Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 8. The US Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 9. Canada Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 10. Europe Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 11. Europe Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 12. Europe Inhalable Drugs Market Value (US$ Mn), By Country, 2018-2033
  - Table 13. Germany Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 14. Germany Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 15. The UK Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 16. The UK Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 17. France Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 18. France Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 19. Spain Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 20. Spain Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 21. Italy Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 22. Italy Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 23. Russia Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 24. Russia Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 25. Netherlands Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 26. Netherlands Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 27. Rest of Europe Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 28. Rest of Europe Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 29. Asia Pacific Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 30. Asia Pacific Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 31. Asia Pacific Inhalable Drugs Market Value (US$ Mn), By Country, 2018-2033
  - Table 32. China Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 33. China Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 34. India Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 35. Global Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 36. Japan Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 37. Japan Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 38. South Korea Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 39. South Korea Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 40. New Zealand Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 41. New Zealand Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 42. Singapore Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 43. Singapore Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 44. Thailand Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 45. Thailand Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 46. Vietnam Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 47. Vietnam Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 48. Rest of Asia Pacific Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 49. Rest of Asia Pacific Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 50. Latin America Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 51. Latin America Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 52. Latin America Inhalable Drugs Market Value (US$ Mn), By Country, 2018-2033
  - Table 53. Brazil Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 54. Brazil Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 55. Mexico Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 56. Mexico Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 57. Rest of Latin America Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 58. Rest of Latin America Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 59. Middle East & Africa Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 60. Middle East & Africa Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 61. Middle East & Africa Inhalable Drugs Market Value (US$ Mn), By Country, 2018-2033
  - Table 62. South Africa Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 63. South Africa Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 64. Saudi Arabia Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 65. Saudi Arabia Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 66. UAE Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 67. UAE Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
  - Table 68. Rest of Middle East & Africa Inhalable Drugs Market Value (US$ Mn), By Type, 2018-2033
  - Table 69. Rest of Middle East & Africa Inhalable Drugs Market Value (US$ Mn), By End-User, 2018-2033
- List of Figures
  - Figure 1. Global Inhalable Drugs Market Snapshot: Market Value (US$ Mn), 2018-2033
  - Figure 2. Opportunity Map
  - Figure 3. Opportunity Orbit
  - Figure 4. Regional Market Share and BPS Analysis in Inhalable Drugs Market
  - Figure 5. Global Inhalable Drugs Market Analysis, By Type, 2018, 2022 and 2032
  - Figure 6. Global Inhalable Drugs Market Attractiveness Analysis, By Type
  - Figure 7. Global Inhalable Drugs Market Analysis, By End-User, 2018, 2022 and 2032
  - Figure 8. Global Inhalable Drugs Market Attractiveness Analysis, By End-User
  - Figure 9. North America Inhalable Drugs Market Analysis, By Type, 2018, 2022 and 2032
  - Figure 10. North America Inhalable Drugs Market Attractiveness Analysis, By Type
  - Figure 11. North America Inhalable Drugs Market (US$ Mn), by Predictive Biomarkers, 2018-2033
  - Figure 12. North America Inhalable Drugs Market (US$ Mn), by Prognostic Biomarkers, 2018-2033
  - Figure 13. North America Inhalable Drugs Market (US$ Mn), by Other Types, 2018-2033
  - Figure 14. North America Inhalable Drugs Market Analysis, By End-User, 2018, 2022 and 2032
  - Figure 15. North America Inhalable Drugs Market Attractiveness Analysis, By End-User
  - Figure 16. North America Inhalable Drugs Market (US$ Mn), by Retail pharmacy, 2018-2033
  - Figure 17. North America Inhalable Drugs Market (US$ Mn), by Hospital pharmacy, 2018-2033
  - Figure 18. North America Inhalable Drugs Market (US$ Mn), by Online pharmacy, 2018-2033
  - Figure 19. North America Inhalable Drugs Market Analysis, By Country, 2018, 2022 and 2032
  - Figure 20. North America Inhalable Drugs Market Attractiveness Analysis, By Country
  - Figure 21. Europe Inhalable Drugs Market Analysis, By Type, 2018, 2022 and 2032
  - Figure 22. Europe Inhalable Drugs Market Attractiveness Analysis, By Type
  - Figure 23. Europe Inhalable Drugs Market (US$ Mn), by Predictive Biomarkers, 2018-2033
  - Figure 24. Europe Inhalable Drugs Market (US$ Mn), by Prognostic Biomarkers, 2018-2033
  - Figure 25. Europe Inhalable Drugs Market (US$ Mn), by Other Types, 2018-2033
  - Figure 26. Europe Inhalable Drugs Market Analysis, By End-User, 2018, 2022 and 2032
  - Figure 27. Europe Inhalable Drugs Market Attractiveness Analysis, By End-User
  - Figure 28. Europe Inhalable Drugs Market (US$ Mn), by Retail pharmacy, 2018-2033
  - Figure 29. Europe Inhalable Drugs Market (US$ Mn), by Hospital pharmacy, 2018-2033
  - Figure 30. Europe Inhalable Drugs Market (US$ Mn), by Online pharmacy, 2018-2033
  - Figure 31. Europe Inhalable Drugs Market Analysis, By Country, 2018, 2022 and 2032
  - Figure 32. Europe Inhalable Drugs Market Attractiveness Analysis, By Country
  - Figure 33. Asia Pacific Inhalable Drugs Market Analysis, By Type, 2018, 2022 and 2032
  - Figure 34. Asia Pacific Inhalable Drugs Market Attractiveness Analysis, By Type
  - Figure 35. Asia Pacific Inhalable Drugs Market (US$ Mn), by Predictive Biomarkers, 2018-2033
  - Figure 36. Asia Pacific Inhalable Drugs Market (US$ Mn), by Prognostic Biomarkers, 2018-2033
  - Figure 37. Asia Pacific Inhalable Drugs Market (US$ Mn), by Other Types, 2018-2033
  - Figure 38. Asia Pacific Inhalable Drugs Market Analysis, By End-User, 2018, 2022 and 2032
  - Figure 39. Asia Pacific Inhalable Drugs Market Attractiveness Analysis, By End-User
  - Figure 40. Asia Pacific Inhalable Drugs Market (US$ Mn), by Retail pharmacy, 2018-2033
  - Figure 41. Asia Pacific Inhalable Drugs Market (US$ Mn), by Hospital pharmacy, 2018-2033
  - Figure 42. Asia Pacific Inhalable Drugs Market (US$ Mn), by Online pharmacy, 2018-2033
  - Figure 43. Asia Pacific Inhalable Drugs Market Analysis, By Country, 2018, 2022 and 2032
  - Figure 44. Asia Pacific Inhalable Drugs Market Attractiveness Analysis, By Country
  - Figure 45. Latin America Inhalable Drugs Market Analysis, By Type, 2018, 2022 and 2032
  - Figure 46. Latin America Inhalable Drugs Market Attractiveness Analysis, By Type
  - Figure 47. Latin America Inhalable Drugs Market (US$ Mn), by Predictive Biomarkers, 2018-2033
  - Figure 48. Latin America Inhalable Drugs Market (US$ Mn), by Prognostic Biomarkers, 2018-2033
  - Figure 49. Latin America Inhalable Drugs Market (US$ Mn), by Other Types, 2018-2033
  - Figure 50. Latin America Inhalable Drugs Market Analysis, By End-User, 2018, 2022 and 2032
  - Figure 51. Latin America Inhalable Drugs Market Attractiveness Analysis, By End-User
  - Figure 52. Latin America Inhalable Drugs Market (US$ Mn), by Retail pharmacy, 2018-2033
  - Figure 53. Latin America Inhalable Drugs Market (US$ Mn), by Hospital pharmacy, 2018-2033
  - Figure 54. Latin America Inhalable Drugs Market (US$ Mn), by Online pharmacy, 2018-2033
  - Figure 55. Latin America Inhalable Drugs Market Analysis, By Country, 2018, 2022 and 2032
  - Figure 56. Latin America Inhalable Drugs Market Attractiveness Analysis, By Country
  - Figure 57. Middle East & Africa Inhalable Drugs Market Analysis, By Type, 2018, 2022 and 2032
  - Figure 58. Middle East & Africa Inhalable Drugs Market Attractiveness Analysis, By Type
  - Figure 59. Middle East & Africa Inhalable Drugs Market (US$ Mn), by Predictive Biomarkers, 2018-2033
  - Figure 60. Middle East & Africa Inhalable Drugs Market (US$ Mn), by Prognostic Biomarkers, 2018-2033
  - Figure 61. Middle East & Africa Inhalable Drugs Market (US$ Mn), by Other Types, 2018-2033
  - Figure 62. Middle East & Africa Inhalable Drugs Market Analysis, By End-User, 2018, 2022 and 2032
  - Figure 63. Middle East & Africa Inhalable Drugs Market Attractiveness Analysis, By End-User
  - Figure 64. Middle East & Africa Inhalable Drugs Market (US$ Mn), by Retail pharmacy, 2018-2033
  - Figure 65. Middle East & Africa Inhalable Drugs Market (US$ Mn), by Hospital pharmacy, 2018-2033
  - Figure 66. Middle East & Africa Inhalable Drugs Market (US$ Mn), by Online pharmacy, 2018-2033
  - Figure 67. Middle East & Africa Inhalable Drugs Market Analysis, By Country, 2018, 2022 and 2032
  - Figure 68. Middle East & Africa Inhalable Drugs Market Attractiveness Analysis, By Country
- Bio-Rad Laboratories
- Almac Group
- Eurofins Scientific
- Cancer Genetics Inc
- Thermo Fisher Scientific Inc
- Epigenomics AG
- US Biomarkers Inc.
- Myriad Genetics
- Aepodia SA
- Roche Diagnostics
- Other Key Players